AST Blood Test (SGOT): Normal Levels and What High AST Means
AST blood test (SGOT): normal AST levels, what a high AST means, why it is not always the liver, and how the AST/ALT ratio points to the cause.
AST (aspartate aminotransferase, also reported as SGOT — serum glutamic-oxaloacetic transaminase) is one of the two transaminases measured on a liver panel. Unlike ALT, AST is not specific to the liver: it is also found in skeletal muscle, the heart, and red blood cells. A high AST can therefore come from physical exertion or muscle injury, not only from the liver. The AST/ALT ratio (the De Ritis ratio) is often what carries the most information. This guide explains what AST is on a blood test, its normal levels, the causes of a high AST, and how to read the AST/ALT ratio.
Key takeaways
- AST = SGOT = serum glutamic-oxaloacetic transaminase — three names for the same enzyme, found in the liver but also in muscle, heart, and red blood cells.1
- An isolated high AST (with a normal ALT) often points to a muscle source — intense exercise, trauma — rather than the liver.12
- Common benchmark: AST is roughly 8–40 U/L in adults — the exact range varies by laboratory.2
- When the liver is the cause, AST and ALT usually rise together; it is their ratio (De Ritis) that helps point toward the cause.1
- A high AST/ALT ratio (> 1, especially > 2) suggests alcohol-related liver disease or fibrosis/cirrhosis; a ratio < 1 is more typical of fatty liver disease.31
- AST is never read alone: rule out a muscle cause, read it alongside ALT and your clinical context.
What is AST on a blood test?
AST (aspartate aminotransferase) is an enzyme that lives inside cells, where it helps process amino acids. It is found in the liver, but also in skeletal muscle, heart muscle, and red blood cells.1 That distribution is exactly what separates it from ALT, which is far more specific to the liver: a high AST is not, on its own, proof of liver injury. When any of those cells are damaged, they leak AST into the bloodstream and the measured level goes up.
AST and SGOT are the same test
If your report says SGOT rather than AST, it is the same enzyme and the same test. AST = SGOT = serum glutamic-oxaloacetic transaminase (the older European abbreviation GOT also appears). The SGOT name is the legacy term and still shows up on plenty of U.S. lab reports and physician orders — MedlinePlus lists "SGOT test" and "serum glutamic oxaloacetic transaminase test" as the official alternative names for the AST test.2 There is no difference in what is measured, how it is measured, or how it is interpreted. Because AST is present in muscle, it can climb after intense physical exercise, an intramuscular injection, or muscle injury — with the liver entirely uninvolved.1
Why is AST measured?
AST is rarely ordered by itself. It comes bundled into a comprehensive metabolic panel (CMP) or a dedicated liver (hepatic) panel, which also reports ALT, alkaline phosphatase (ALP), bilirubin, and albumin.4 Clinicians use it to:
- complete the work-up of a liver problem, together with ALT and the AST/ALT ratio;
- help point toward an alcohol-related cause or liver fibrosis (the De Ritis ratio);3
- contribute to the assessment of muscle injury, alongside other markers such as creatine kinase (CK);
- monitor the tolerance of certain medications that can affect the liver.5
Normal AST levels
| Parameter | Typical range (adults) |
|---|---|
| AST (SGOT) | ~ 8 – 40 U/L |
Units are U/L (units per liter). These thresholds vary by laboratory, method, sex, and age — men typically run slightly higher than women.2 Intense physical exercise the day before can raise AST from a muscle source and skew the interpretation: it is better to avoid a hard workout before the blood draw, and to mention it if you did one. The reference range that matters is the one printed on your own report.
Interpreting your results
High AST: liver or muscle?
The first question in front of a high AST is: is it coming from the liver, or from somewhere else?1
- If ALT is high at the same time, the source is most often hepatic — fatty liver disease (MASLD), alcohol, medications, viral hepatitis. The approach is then the same as for transaminases in general.
- If AST is high but ALT is normal, think first of a non-hepatic source: intense exercise, trauma, or muscle disease — AST is, alongside creatine kinase, a marker of muscle damage, for example in rhabdomyolysis.6 Less commonly, a cardiac cause or hemolysis (destruction of red blood cells). MedlinePlus also notes non-liver contributors such as heart problems or procedures, pancreatitis, deep burns, and seizures.2 Finally, a lab phenomenon called macro-AST (the enzyme bound to an immunoglobulin) can explain a persistently and isolated high AST with no underlying disease at all.
The degree of elevation matters too. A mild elevation (up to about 5× the upper limit) most often reflects fatty liver disease, alcohol, or medications and supplements. A marked elevation (10× the upper limit or more) points to acute injury: acute viral hepatitis, drug- or toxin-induced liver injury such as acetaminophen overdose, or reduced blood flow to the liver (ischemic hepatitis).7
A high AST is a flag, not a diagnosis. The usual next step is a repeat test plus a targeted work-up: a careful history (exercise, alcohol, medications, supplements, metabolic risk factors), viral hepatitis testing, imaging or elastography, and noninvasive fibrosis scores such as FIB-4.7
The AST/ALT ratio (De Ritis ratio)
When both transaminases are elevated, their ratio (AST ÷ ALT) helps orient the diagnosis:31
- Low ratio (< 1): typical of metabolic dysfunction-associated steatotic liver disease (MASLD, formerly NAFLD**)** and of many common liver conditions, where ALT dominates.8
- High ratio (> 1, especially > 2): suggests alcoholic hepatitis or advanced fibrosis/cirrhosis, where AST takes the lead. In alcohol-related liver disease, the classic picture is an AST above the ALT, together with a high GGT and a raised MCV.9
This ratio is an orienting clue, not a diagnosis. It also carries prognostic value — a high ratio is associated with an increased risk of liver-related outcomes — but it is always read alongside the rest of the panel and your clinical context.3
What about symptoms?
Like ALT, a high AST is often silent. Liver red flags — jaundice, dark urine, major fatigue — mean you should see a clinician, and they shape the first steps of the work-up.10 A rise after intense exercise, with no symptoms, is on the other hand most often benign and transient.
How to lower a high AST
It all depends on the cause. If the AST is of muscle origin (hard training), it comes back down on its own with rest — there is nothing to "treat." If the origin is hepatic, the levers are the same as for transaminases generally: weight loss and physical activity for fatty liver disease, cutting back on alcohol, and reviewing your medications with your doctor, since some cause drug-induced liver injury (DILI).11125 There is no miracle "detox": you treat the cause, over weeks to a few months.
What can affect your AST
AST depends on the liver, but also on muscle activity (intense exercise, intramuscular injections, trauma), the heart, possible hemolysis, and the macro-AST phenomenon. Alcohol readily raises it (with an increased AST/ALT ratio). Exercise the day before is the classic trap — remember to mention it.
When to see a doctor
Talk with your primary care provider (PCP) if your AST is above your lab's range — especially if it is persistently elevated, very high, or paired with symptoms such as jaundice, dark urine, abdominal pain, swelling, confusion, or unusual fatigue. Most mildly elevated results are handled with simple steps: a repeat test after avoiding exercise and alcohol, a review of medications and supplements, and an evaluation for fatty liver disease and viral hepatitis, with attention to metabolic risk factors.7 A markedly high AST, or one with a rising bilirubin and abnormal clotting, needs prompt medical attention.
Recent research
According to recent publications indexed on PubMed:
- The AST/ALT ratio as a prognostic marker. Large studies show that a high aspartate-to-alanine ratio is associated with an increased risk of liver-related mortality; "dynamic" versions of the ratio further improve risk prediction in the general population.3
- Don't overlook the extra-hepatic source. Guidelines emphasize that an isolated high AST (with a normal ALT) should prompt a search for a muscle or cardiac cause, or even macro-AST, before concluding the liver is at fault.16
- When the liver is the cause, lifestyle comes first. As with ALT, weight loss and physical activity remain the foundation of treating fatty liver disease — the leading cause of elevated transaminases.1211
- A cardiometabolic reading. Elevated transaminases (AST included) are tightly linked to metabolic syndrome and to fatty liver disease in type 2 diabetes, which is why the result belongs in your overall picture.1314 A 2023 systematic review and meta-analysis (76,000+ people with metabolic syndrome vs. 200,000+ without) found AST, ALT, and GGT all significantly higher in people with metabolic syndrome.15
These findings concern interpretation and management; they do not authorize self-medication and do not replace your physician's advice.
Get your AST interpreted by AI DiagMe
An AST is never read alone: its meaning depends on ALT (and on their ratio), on a possible muscle cause, on GGT, bilirubin, and your context. That cross-referencing is what gives the result its real value.
👉 AI DiagMe interprets your lab results — blood, urine, or stool — taking your whole context into account, in plain language. An informational service that does not provide a diagnosis and complements, never replaces, your physician.
Frequently asked questions
What is AST in a blood test?
Are AST and SGOT the same thing?
What is a normal AST level?
Does a high AST always mean a liver problem?
What is the AST/ALT (De Ritis) ratio?
Can exercise raise AST?
Bottom line
AST (SGOT) is not specific to the liver: muscle, heart, and red blood cells contain it too. An isolated high AST (with a normal ALT) often means a muscle cause — exercise, trauma — rather than a liver one. When the liver is involved, the AST/ALT ratio does the orienting: < 1 for fatty liver disease, > 1–2 for alcohol or fibrosis. Remember the benchmark (~8–40 U/L, varies by lab) and the exercise trap the day before. No single value is read alone: what counts is the full set of your markers and your profile — which is what AI DiagMe provides, alongside your physician.
Sources
Official sources and peer-reviewed publications (PubMed) used for this guide:
Footnotes
-
Kwo PY, Cohen SM, Lim JK. ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries. American Journal of Gastroenterology, 2017. PubMed · DOI ↩ ↩2 ↩3 ↩4 ↩5 ↩6 ↩7 ↩8 ↩9
-
MedlinePlus (U.S. National Library of Medicine, NIH) — AST Test. medlineplus.gov ↩ ↩2 ↩3 ↩4 ↩5
-
Song IA, Jang ES, Oh TK. Validation of Dynamic Aspartate-to-Alanine Aminotransferase Ratio for Predicting Liver Disease Mortality. Hepatology Communications, 2021. PubMed · DOI ↩ ↩2 ↩3 ↩4 ↩5
-
MedlinePlus (U.S. National Library of Medicine, NIH) — Liver Function Tests. medlineplus.gov ↩
-
Hosack T, Damry D, Biswas S. Drug-induced liver injury: a comprehensive review. Therapeutic Advances in Gastroenterology, 2023. PubMed · DOI ↩ ↩2
-
Młynarska E, Krzemińska J, Wronka M, Franczyk B, Rysz J. Rhabdomyolysis-Induced AKI (RIAKI) Including the Role of COVID-19. International Journal of Molecular Sciences, 2022. PubMed · DOI ↩ ↩2
-
Kwo PY, Masuoka HC, Schaefer EA, Friedman LS. Evaluation of Abnormal Liver Biochemical Test Results. Gastroenterology, 2026. PubMed · DOI ↩ ↩2 ↩3
-
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK, NIH) — Nonalcoholic Fatty Liver Disease (NAFLD) & NASH. niddk.nih.gov ↩
-
Torruellas C, French SW, Medici V. Diagnosis of alcoholic liver disease. World Journal of Gastroenterology, 2014. PubMed · DOI ↩
-
Fargo MV, Grogan SP, Saguil A. Evaluation of Jaundice in Adults. American Family Physician, 2017. PubMed ↩
-
Fernández T et al. Lifestyle changes in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis. PLoS One, 2022. PubMed · DOI ↩ ↩2
-
European Association for the Study of the Liver (EASL-EASD-EASO). Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). Journal of Hepatology, 2024. PubMed · DOI ↩ ↩2
-
Ghotbi S et al. Evaluation of elevated serum liver enzymes and metabolic syndrome in the PERSIAN Guilan cohort study population. Heliyon, 2024. PubMed · DOI ↩
-
Younossi ZM et al. The Global Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Among Patients With Type 2 Diabetes. Clinical Gastroenterology and Hepatology, 2024. PubMed · DOI ↩
-
Raya-Cano E, Molina-Luque R, Vaquero-Abellán M, et al. Metabolic syndrome and transaminases: systematic review and meta-analysis. Diabetology & Metabolic Syndrome, 2023. PubMed · DOI ↩